These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11298482)

  • 1. Atorvastatin: in the management of hyperlipidaemia.
    Ray SK; Rege NN
    J Postgrad Med; 2000; 46(3):242-3. PubMed ID: 11298482
    [No Abstract]   [Full Text] [Related]  

  • 2. Atorvastatin: a new agent for hyperlipidemia.
    Kupecz D
    Nurse Pract; 1997 Nov; 22(11):87-8, 90, 93. PubMed ID: 9403876
    [No Abstract]   [Full Text] [Related]  

  • 3. Liptruzet: a combination of ezetimibe and atorvastatin.
    Med Lett Drugs Ther; 2013 Jun; 55(1419):49-50. PubMed ID: 23797796
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of cardiovascular diseases: Value of CSE inhibitors in the management of lipid metabolism disorders].
    Z Kardiol; 1998 Apr; 87(4 Suppl Stellenwer):1-4. PubMed ID: 9618894
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fluvastatin in a comparative study. Are there substance-specific differences between various CSE-inhibitors?].
    Internist (Berl); 1999 Mar; 40(3 Suppl Gibt Es):1-4. PubMed ID: 10192028
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effective cholesterol and triglyceride lowering with atorvastatin].
    Internist (Berl); 1996 Aug; 37(8 Suppl Effektive):1-8. PubMed ID: 9404527
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis.
    Kuryata OV; Yegorova YV
    Kardiol Pol; 2006 Jan; 64(1):44-8; discussion 49-50. PubMed ID: 16444629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin.
    Hyatt PJ
    Br J Hosp Med; 1997 Oct 1-14; 58(7):333-6. PubMed ID: 9509055
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of atorvastatin (10 mg) on hemostatic and inflammatory parameters in hyperlipidemic patients with angiographically proven coronary artery disease.
    Tekin A; Tekin G; Güzelsoy D; Kaya A; Gürel CV; Yiğit Z; Ulutin T
    Am J Cardiol; 2004 Jul; 94(2):206-9. PubMed ID: 15246903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Journal Watch: evidence that Atorvastatin reduces the risk of stroke and myocardial infarction in patients with type 2 diabetes, but with no evidence of dyslipidaemia.
    Gangaidzo IT
    Cent Afr J Med; 2005; 51(11-12):125-6. PubMed ID: 17447346
    [No Abstract]   [Full Text] [Related]  

  • 11. Atorvastatin--a new lipid-lowering drug.
    Med Lett Drugs Ther; 1997 Mar; 39(997):29-31. PubMed ID: 9121394
    [No Abstract]   [Full Text] [Related]  

  • 12. Atorvastatin versus revascularization treatment (AVERT): fact or fancy?
    Singh BM; Puri S; Saucedo J; Talley JD
    Am Heart J; 2000 Jul; 140(1):6-9. PubMed ID: 10874254
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipitor (atorvastatin calcium) tablets.
    Claussen DW
    Gastroenterol Nurs; 1998; 21(5):219-20. PubMed ID: 9830966
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension.
    Kosmidou MS; Hatzitolios AI; Adamidou A; Giannopoulos S; Raikos N; Parharidis G; Milionis HJ
    Am J Hypertens; 2008 Mar; 21(3):303-9. PubMed ID: 18202666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk.
    Velussi M
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What is new? Therapy with lipid lowering agents].
    Internist (Berl); 1997 Nov; 38(11 Suppl Therapie):1-8. PubMed ID: 9403084
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversal of atherosclerosis with aggressive lipid lowering.
    Farmer JA
    Curr Atheroscler Rep; 2005 Mar; 7(2):86-7. PubMed ID: 15727721
    [No Abstract]   [Full Text] [Related]  

  • 18. Atorvastatin for protease inhibitor-related hyperlipidaemia.
    Murillas J; Martín T; Ramos A; Portero JL
    AIDS; 1999 Jul; 13(11):1424-5. PubMed ID: 10449305
    [No Abstract]   [Full Text] [Related]  

  • 19. A low-density lipoprotein-dependent effect of atorvastatin upon the systolic blood pressure reduction: meta-regression analyses of randomized trials.
    Takagi H; Umemoto T;
    Int J Cardiol; 2013 Dec; 170(1):e14-6. PubMed ID: 24169537
    [No Abstract]   [Full Text] [Related]  

  • 20. Polymorphisms in the multidrug resistance-1 (MDR1) gene influence the response to atorvastatin treatment in a gender-specific manner.
    Kajinami K; Brousseau ME; Ordovas JM; Schaefer EJ
    Am J Cardiol; 2004 Apr; 93(8):1046-50. PubMed ID: 15081455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.